Controlling gene expression to halt cancer growth
p(image-right). !http://newsinfo.nd.edu/assets/48192/wiest_olaf_web_comp.jpg(Olaf Wiest)! NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least. But difficult doesn’t mean impossible, and "Olaf Wiest":http://newsinfo.nd.edu/for-the-media/nd-experts/faculty/olaf-wiest/, professor of chemistry and biochemistry at the University of Notre Dame, is one of a group of collaborators studying the effects of a specific molecule (JQ1) on the trigger that controls the growth of this form of cancer.
Read More about Controlling gene expression to halt cancer growth